title: Renal medullary endothelin-1 is decreased in Dahl salt-sensitive rats.
abstract: Although it is well established that the renal endothelin (ET-1) system plays an important role in regulating sodium excretion and blood pressure through activation of renal medullary ET(B) receptors, the role of this system in Dahl salt-sensitive (DS) hypertension is unclear. The purpose of this study was to determine whether the DS rat has abnormalities in the renal medullary endothelin system when maintained on a high sodium intake. The data indicate that Dahl salt-resistant rats (DR) on a high-salt diet had a six-fold higher urinary endothelin excretion than in the DR rats with low Na(+) intake (17.8 ± 4 pg/day vs. 112 ± 44 pg/day). In sharp contrast, urinary endothelin levels increased only twofold in DS rats in response to a high Na(+) intake (13 ± 2 pg/day vs. 29.8 ± 5.5 pg/day). Medullary endothelin concentration in DS rats on a high-Na(+) diet was also significantly lower than DR rats on a high-Na(+) diet (31 ± 2.8 pg/mg vs. 70.9 ± 5 pg/mg). Furthermore, DS rats had a significant reduction in medullary ET(B) receptor expression compared with DR rats while on a high-Na(+) diet. Finally, chronic infusion of ET-1 directly into the renal medulla blunted Dahl salt-sensitive hypertension. These data indicate that a decrease in medullary production of ET-1 in the DS rat could play an important role in the development of salt-sensitive hypertension observed in the DS rat.
authors: University of Mississippi Medical Center, Department of Physiology and Biophysics, Jackson, Mississippi, USA.
authors: Joshua S
authors: JS
authors: Speed
authors: Babbette
authors: B
authors: LaMarca
authors: Hunter
authors: H
authors: Berry
authors: Kathy
authors: K
authors: Cockrell
authors: Eric M
authors: EM
authors: George
authors: Joey P
authors: JP
authors: Granger
references: Hypertension. 1998 Jan;31(1 Pt 2):397-402
references: 9453335
references: Hypertension. 2009 Feb;53(2):324-30
references: 19104001
references: Circulation. 2003 Nov 4;108(18):2184-90
references: 14597580
references: J Am Soc Nephrol. 2010 May;21(5):833-43
references: 20338996
references: Am J Hypertens. 1997 May;10(5 Pt 2):63S-67S
references: 9160783
references: J Cardiovasc Pharmacol. 1991;17 Suppl 7:S484-91
references: 1725420
references: Am J Physiol Renal Physiol. 2006 Dec;291(6):F1274-80
references: 16868309
references: Nature. 1988 Mar 31;332(6163):411-5
references: 2451132
references: Am J Physiol Renal Physiol. 2011 Mar;300(3):F650-6
references: 21177779
references: Hypertension. 1997 Sep;30(3 Pt 2):682-6
references: 9323005
references: Hypertension. 1995 Dec;26(6 Pt 2):1030-4
references: 7498962
references: Curr Opin Nephrol Hypertens. 2000 Mar;9(2):157-64
references: 10757221
references: Am J Physiol. 1991 Mar;260(3 Pt 2):F331-9
references: 2000950
references: Am J Physiol Renal Physiol. 2000 Aug;279(2):F326-33
references: 10919853
references: Hypertens Res. 2009 Oct;32(10):846-52
references: 19662022
references: Am J Physiol Renal Physiol. 2001 Jul;281(1):F144-50
references: 11399655
references: J Clin Invest. 2004 Aug;114(4):504-11
references: 15314687
references: J Am Soc Nephrol. 2000 May;11(5):835-845
references: 10770961
references: Curr Opin Nephrol Hypertens. 2006 Jan;15(1):34-40
references: 16340664
references: Pharmacol Rev. 1994 Sep;46(3):325-415
references: 7831383
references: Hypertension. 2011 Apr;57(4):772-9
references: 21357275
references: Hypertension. 2008 Sep;52(3):452-9
references: 18678788
references: Eur J Pharmacol. 1989 Apr 25;163(2-3):379-82
references: 2656276
references: Cell Physiol Biochem. 2008;21(1-3):117-22
references: 18209478
references: J Biol Chem. 2009 Jan 16;284(3):1454-60
references: 19033447
references: Hypertension. 1999 Sep;34(3):514-9
references: 10489403